MobileMedMinder: A Networked Aide for Medication Compliance

MobileMedMinder：药物合规性的网络助手

• 批准号: 8158744
• 金额: $ 49.96万
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2012-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8158744
• 关键词: Academic Medical Centers; Caregivers; Chronic Disease; Collaborations; Communication; Development; Devices; Diabetes Mellitus; Disease Management; Doctor of Medicine; Electronics; Enrollment; Goals; Hypertension; Intake; Internet; Link; Measures; Mental Depression; Methodology; Monitor; Ohio; Patients; Pharmaceutical Preparations; Phase; Physicians; Recommendation; Small Business Innovation Research Grant; Social Network; Solutions; Study Subject; System; Testing; Time; Wireless Technology; behavior change; compliance behavior; medication compliance; usability; voice recognition

Under Phase I of the project (SBIR PHS 2008-1, "Development of Methodology for Measuring and Enhancing Compliance for Medications, Topic 33), the MobileMedMinder was successfully demonstrated. Phase II will involve collaboration to develop and commercialize the MobileMedMinder. This product will allow users to enroll and verify medication intake using the existing mobile devices, and link seemlessly to web through wireless. MobileMedMinder will provide the following: 1) automatic or simi-automatic entry of medication information through Medscanning, electronic pick lists, voice recognition. 2) Real-time communication with an on-line server where medication can be monitored and recommendations made from automated systems, caregivers or physicians directly or through social networking solutions. 3) If successful, MobileMedMinder can be extended as a mobile platform for chronic disease management system, such as diabetes, depression, hypertension, etc. A user-centered usability testing and subject study at the Ohio State University Medical Center managed by collaborator, Robert M. Guthrie, M.D., is planned to provide a comprehensive, non-intrusive, portable solution in support of medication compliance. The ultimate goal is to develop a product for use by patients on a mobile/web platform to promote medication compliance and behavior change that can be subsequently commercialized.

在该项目的第一阶段(SBIR PHS 2008-1，“开发测量和提高药物依从性的方法学，主题33)”中，已经成功演示了MobileMedMinder。第二阶段将合作开发MobileMedMinder并将其商业化。该产品将允许用户使用现有的移动设备注册和验证药物摄入，并通过无线连接到网络。 MobileMedMinder将提供以下功能：1)通过MedScanning、电子挑选清单、语音识别自动或半自动输入药物信息。2)与在线服务器进行实时通信，在该服务器中，可以直接或通过社交网络解决方案从自动化系统、护理人员或医生那里监控药物并提供建议。3)如果成功，MobileMedMinder可以扩展为糖尿病、抑郁症、高血压等慢性病管理系统的移动平台。 俄亥俄州立大学医学中心由合作者罗伯特·M·格思里医学博士管理的以用户为中心的可用性测试和主题研究计划提供一种全面的、非侵入性的便携式解决方案，以支持药物依从性。最终目标是开发一种产品，供患者在移动/网络平台上使用，以促进服药依从性和行为改变，并可随后商业化。